|
P0853 A Swiss pharmaceutical corporation's participation with American companies in a collaborative effort to make the process of evaluating and reporting adverse side effects global and uniform to meet regulatory and labeling requirements of the US government, with all data evaluation taking place in England pursuant to policies controlled by the Swiss corporations, was insufficient to constitute the minimum contact necessary to confer jurisdiction on California courts.CitationHOFFMANLA ROCHE v SUPERIOR COURT (Pharmaceutical Data) 130 CA4 782 [See: Von's v Seabest 14 C4 434, T/AT 1/97]
|
|
